Literature DB >> 20420935

Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease.

Lesley Jones1, Denise Harold, Julie Williams.   

Abstract

Alzheimer's disease (AD) is the most common cause of dementia in the elderly and presents a great burden to sufferers and to society. The genetics of rare Mendelian forms of AD have been central to our understanding of AD pathogenesis for the past twenty years and now the genetics of the common form of the disease in the elderly is beginning to be unravelled by genome-wide association studies. Four new genes for common AD have been revealed in the past year, CLU, CR1, PICALM and BIN1. Their possible involvement in lipid metabolism and how that relates to AD is discussed here. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20420935     DOI: 10.1016/j.bbalip.2010.04.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  38 in total

Review 1.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

Review 2.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

3.  Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.

Authors:  Lewis H Kuller; Oscar L Lopez
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

4.  Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena.

Authors:  Yan Ji; Xiaowan Wang; Colin Kalicki; Blaise W Menta; Megan Baumgardner; Scott J Koppel; Ian W Weidling; Judit Perez-Ortiz; Heather M Wilkins; Russell H Swerdlow
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 5.  Nutrition and brain aging: how can we move ahead?

Authors:  P Barberger-Gateau
Journal:  Eur J Clin Nutr       Date:  2014-08-27       Impact factor: 4.016

6.  Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.

Authors:  Jalal Gharesouran; Maryam Rezazadeh; Aziz Khorrami; Morteza Ghojazadeh; Mahnaz Talebi
Journal:  J Mol Neurosci       Date:  2014-07-15       Impact factor: 3.444

Review 7.  Alzheimer's genetics in the GWAS era: a continuing story of 'replications and refutations'.

Authors:  Lars Bertram
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

8.  Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis.

Authors:  Hua Cheng; Miao Wang; Jian-Liang Li; Nigel J Cairns; Xianlin Han
Journal:  J Neurochem       Date:  2013-07-30       Impact factor: 5.372

9.  Risk-reducing Apolipoprotein E and Clusterin genotypes protect against the consequences of poor vascular health on executive function performance and change in nondemented older adults.

Authors:  G Peggy McFall; Shraddha Sapkota; Kirstie L McDermott; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2016-03-10       Impact factor: 4.673

Review 10.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.